Cargando…

Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas

SIMPLE SUMMARY: Pheochromocytomas and paragangliomas are rare neural-crest-derived tumors with variable prognosis. In an era of tailored treatment strategies, medical imaging plays a crucial role in the surgeries, image-guided procedures, chemotherapies, immunotherapies, and radionuclide therapies i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabiache, Gildas, Zadro, Charline, Rozenblum, Laura, Vezzosi, Delphine, Mouly, Céline, Thoulouzan, Matthieu, Guimbaud, Rosine, Otal, Philippe, Dierickx, Lawrence, Rousseau, Hervé, Trepanier, Christopher, Dercle, Laurent, Mokrane, Fatima-Zohra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526298/
https://www.ncbi.nlm.nih.gov/pubmed/37760633
http://dx.doi.org/10.3390/cancers15184666
_version_ 1785110988587008000
author Gabiache, Gildas
Zadro, Charline
Rozenblum, Laura
Vezzosi, Delphine
Mouly, Céline
Thoulouzan, Matthieu
Guimbaud, Rosine
Otal, Philippe
Dierickx, Lawrence
Rousseau, Hervé
Trepanier, Christopher
Dercle, Laurent
Mokrane, Fatima-Zohra
author_facet Gabiache, Gildas
Zadro, Charline
Rozenblum, Laura
Vezzosi, Delphine
Mouly, Céline
Thoulouzan, Matthieu
Guimbaud, Rosine
Otal, Philippe
Dierickx, Lawrence
Rousseau, Hervé
Trepanier, Christopher
Dercle, Laurent
Mokrane, Fatima-Zohra
author_sort Gabiache, Gildas
collection PubMed
description SIMPLE SUMMARY: Pheochromocytomas and paragangliomas are rare neural-crest-derived tumors with variable prognosis. In an era of tailored treatment strategies, medical imaging plays a crucial role in the surgeries, image-guided procedures, chemotherapies, immunotherapies, and radionuclide therapies involved in the diagnosis and treatment of these tumors. Medical imaging helps to confirm the diagnosis, guide surgical resection, assess metastatic staging, and select patients for specific therapies. In this step-by-step review, we perform a comprehensive analysis of recent imaging modalities developed for pheochromocytomas and paragangliomas by covering their content and terminology as well as discussing the future implications of artificial intelligence. ABSTRACT: In this comprehensive review, we aimed to discuss the current state-of-the-art medical imaging for pheochromocytomas and paragangliomas (PPGLs) diagnosis and treatment. Despite major medical improvements, PPGLs, as with other neuroendocrine tumors (NETs), leave clinicians facing several challenges; their inherent particularities and their diagnosis and treatment pose several challenges for clinicians due to their inherent complexity, and they require management by multidisciplinary teams. The conventional concepts of medical imaging are currently undergoing a paradigm shift, thanks to developments in radiomic and metabolic imaging. However, despite active research, clinical relevance of these new parameters remains unclear, and further multicentric studies are needed in order to validate and increase widespread use and integration in clinical routine. Use of AI in PPGLs may detect changes in tumor phenotype that precede classical medical imaging biomarkers, such as shape, texture, and size. Since PPGLs are rare, slow-growing, and heterogeneous, multicentric collaboration will be necessary to have enough data in order to develop new PPGL biomarkers. In this nonsystematic review, our aim is to present an exhaustive pedagogical tool based on real-world cases, dedicated to physicians dealing with PPGLs, augmented by perspectives of artificial intelligence and big data.
format Online
Article
Text
id pubmed-10526298
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105262982023-09-28 Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas Gabiache, Gildas Zadro, Charline Rozenblum, Laura Vezzosi, Delphine Mouly, Céline Thoulouzan, Matthieu Guimbaud, Rosine Otal, Philippe Dierickx, Lawrence Rousseau, Hervé Trepanier, Christopher Dercle, Laurent Mokrane, Fatima-Zohra Cancers (Basel) Review SIMPLE SUMMARY: Pheochromocytomas and paragangliomas are rare neural-crest-derived tumors with variable prognosis. In an era of tailored treatment strategies, medical imaging plays a crucial role in the surgeries, image-guided procedures, chemotherapies, immunotherapies, and radionuclide therapies involved in the diagnosis and treatment of these tumors. Medical imaging helps to confirm the diagnosis, guide surgical resection, assess metastatic staging, and select patients for specific therapies. In this step-by-step review, we perform a comprehensive analysis of recent imaging modalities developed for pheochromocytomas and paragangliomas by covering their content and terminology as well as discussing the future implications of artificial intelligence. ABSTRACT: In this comprehensive review, we aimed to discuss the current state-of-the-art medical imaging for pheochromocytomas and paragangliomas (PPGLs) diagnosis and treatment. Despite major medical improvements, PPGLs, as with other neuroendocrine tumors (NETs), leave clinicians facing several challenges; their inherent particularities and their diagnosis and treatment pose several challenges for clinicians due to their inherent complexity, and they require management by multidisciplinary teams. The conventional concepts of medical imaging are currently undergoing a paradigm shift, thanks to developments in radiomic and metabolic imaging. However, despite active research, clinical relevance of these new parameters remains unclear, and further multicentric studies are needed in order to validate and increase widespread use and integration in clinical routine. Use of AI in PPGLs may detect changes in tumor phenotype that precede classical medical imaging biomarkers, such as shape, texture, and size. Since PPGLs are rare, slow-growing, and heterogeneous, multicentric collaboration will be necessary to have enough data in order to develop new PPGL biomarkers. In this nonsystematic review, our aim is to present an exhaustive pedagogical tool based on real-world cases, dedicated to physicians dealing with PPGLs, augmented by perspectives of artificial intelligence and big data. MDPI 2023-09-21 /pmc/articles/PMC10526298/ /pubmed/37760633 http://dx.doi.org/10.3390/cancers15184666 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gabiache, Gildas
Zadro, Charline
Rozenblum, Laura
Vezzosi, Delphine
Mouly, Céline
Thoulouzan, Matthieu
Guimbaud, Rosine
Otal, Philippe
Dierickx, Lawrence
Rousseau, Hervé
Trepanier, Christopher
Dercle, Laurent
Mokrane, Fatima-Zohra
Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas
title Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas
title_full Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas
title_fullStr Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas
title_full_unstemmed Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas
title_short Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas
title_sort image-guided precision medicine in the diagnosis and treatment of pheochromocytomas and paragangliomas
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526298/
https://www.ncbi.nlm.nih.gov/pubmed/37760633
http://dx.doi.org/10.3390/cancers15184666
work_keys_str_mv AT gabiachegildas imageguidedprecisionmedicineinthediagnosisandtreatmentofpheochromocytomasandparagangliomas
AT zadrocharline imageguidedprecisionmedicineinthediagnosisandtreatmentofpheochromocytomasandparagangliomas
AT rozenblumlaura imageguidedprecisionmedicineinthediagnosisandtreatmentofpheochromocytomasandparagangliomas
AT vezzosidelphine imageguidedprecisionmedicineinthediagnosisandtreatmentofpheochromocytomasandparagangliomas
AT moulyceline imageguidedprecisionmedicineinthediagnosisandtreatmentofpheochromocytomasandparagangliomas
AT thoulouzanmatthieu imageguidedprecisionmedicineinthediagnosisandtreatmentofpheochromocytomasandparagangliomas
AT guimbaudrosine imageguidedprecisionmedicineinthediagnosisandtreatmentofpheochromocytomasandparagangliomas
AT otalphilippe imageguidedprecisionmedicineinthediagnosisandtreatmentofpheochromocytomasandparagangliomas
AT dierickxlawrence imageguidedprecisionmedicineinthediagnosisandtreatmentofpheochromocytomasandparagangliomas
AT rousseauherve imageguidedprecisionmedicineinthediagnosisandtreatmentofpheochromocytomasandparagangliomas
AT trepanierchristopher imageguidedprecisionmedicineinthediagnosisandtreatmentofpheochromocytomasandparagangliomas
AT derclelaurent imageguidedprecisionmedicineinthediagnosisandtreatmentofpheochromocytomasandparagangliomas
AT mokranefatimazohra imageguidedprecisionmedicineinthediagnosisandtreatmentofpheochromocytomasandparagangliomas